packageAvelumab

avelumab

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Avelumab is a fully human anti-PD-L1 monoclonal antibody used as cancer immunotherapy, studied for tumours including Merkel cell carcinoma, bladder, ovarian, stomach, kidney, head and neck, and lung cancers, and mesothelioma. It is an approved anticancer medicine, with additional uses still under investigation.

Summary written by glm-5.3-flash from Wikidata Q21083261 and the WHO ATC classification; not checked by a person.

name:avelumab
ATC codes:L01FF04
DrugBank:DB11945
Wikidata:Q21083261
molar mass:147000 g/mol (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown